
Rebopag 75mg Tablet
Marketer
MSN Laboratories
Salt Composition
Eltrombopag (75mg)
Overview Rebopag 75mg Tablet
Eltrombopag 75mg tablets are indicated for the management of thrombocytopenia stemming from chronic immune (idiopathic) thrombocytopenic purpura (ITP) or chronic hepatitis C virus (HCV) infection. This medication also addresses severe aplastic anemia. Acting as a thrombopoietin receptor agonist, eltrombopag stimulates platelet production, thereby improving hemostasis. Adhere strictly to your physician's prescribed dosage and regimen. Administration on an empty stomach is acceptable. Swallow the tablet whole; avoid crushing, chewing, or breaking. Report any known drug allergies to your doctor. Commonly observed adverse effects include nausea, vomiting, diarrhea, upper respiratory infection, and urinary tract infection. Consult your doctor if these side effects are troublesome; management strategies may be available. Prior to commencing treatment, disclose any existing health conditions and all concurrent medications. Dosage modification might be necessary for patients with hepatic impairment; discuss this with your doctor.
Uses of Rebopag 75mg Tablet
Reduced thrombocytes from immune thrombocytopenia or hepatitis C; managing critical bone marrow failure.
Major Benefits of Rebopag 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Rebopag 75mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Rebopag 75mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Rebopag 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 75mg Rebopag Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
How Rebopag 75mg Tablet works:
Rebopag 75mg tablets act as a thrombopoietin receptor activator, boosting the production of platelets within the bloodstream. These platelets are crucial for minimizing or halting hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Rebopag 75mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Rebopag 75mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Rebopag 75mg Tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Rebopag 75mg Tablet, which can induce dizziness and reduced alertness, potentially impacting safe operation of a vehicle.
KidneySAFE IF PRESCRIBED
Rebopag 75mg tablets are considered safe for use by individuals with kidney disease; no dosage modification is typically needed. Nevertheless, disclosure of any kidney condition to your physician is recommended. Routine monitoring of kidney function during treatment with this medication is advisable.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Rebopag 75mg tablets, as dose modification may be necessary. Physician consultation is recommended.
What if you forget to take Rebopag 75mg Tablet :
Omit any missed dose of Rebopag 75mg Tablet; resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rebopag 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Thrombopoietin receptor activator |
